Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
Recruiting · NCT02579967 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies | Hemic and Lymphatic Diseases, Infections, Opportunistic Infections, T cell immunodeficiency primary, autoimmune disease, common variable immunodeficiency, immune system disorder, immunoproliferative disorder, inborn error of immunity, lymphatic system disorder, lymphoproliferative syndrome | Recruiting | Phase 2 | 2026-09-28 | NCT02579967 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| National Institutes of Health Clinical Center | Bethesda | United States | 800 |
| National Marrow Donor Program | Minneapolis | United States | 1 |